HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,002,226 | +4.5% | 1,741,485 | -0.7% | 0.01% | +12.5% |
| Q2 2023 | $149,321,342 | +4.0% | 1,753,833 | +1.1% | 0.01% | 0.0% |
| Q1 2023 | $143,553,045 | -46.1% | 1,734,780 | -48.7% | 0.01% | 0.0% |
| Q4 2022 | $266,119,354 | +111.8% | 3,383,590 | +99.4% | 0.01% | 0.0% |
| Q3 2022 | $125,643,000 | +15.5% | 1,697,184 | +1.7% | 0.01% | +14.3% |
| Q2 2022 | $108,819,000 | -0.8% | 1,669,517 | -3.8% | 0.01% | +40.0% |
| Q1 2022 | $109,661,000 | +22.3% | 1,734,589 | +2.6% | 0.01% | +25.0% |
| Q4 2021 | $89,701,000 | -23.5% | 1,691,193 | +1.8% | 0.00% | -33.3% |
| Q3 2021 | $117,267,000 | +5.1% | 1,661,235 | -0.8% | 0.01% | 0.0% |
| Q2 2021 | $111,619,000 | -18.1% | 1,674,954 | +36.5% | 0.01% | -25.0% |
| Q1 2021 | $136,218,000 | -6.1% | 1,227,079 | +0.5% | 0.01% | -11.1% |
| Q4 2020 | $145,024,000 | +36.0% | 1,221,253 | -0.1% | 0.01% | +28.6% |
| Q3 2020 | $106,643,000 | -5.5% | 1,222,269 | -3.0% | 0.01% | -12.5% |
| Q2 2020 | $112,865,000 | -32.4% | 1,260,222 | -24.8% | 0.01% | -46.7% |
| Q1 2020 | $166,920,000 | -12.1% | 1,674,890 | +1.4% | 0.02% | +15.4% |
| Q4 2019 | $189,845,000 | -10.5% | 1,652,266 | -1.8% | 0.01% | -18.8% |
| Q3 2019 | $212,228,000 | +2.3% | 1,682,482 | -2.4% | 0.02% | +6.7% |
| Q2 2019 | $207,392,000 | +37.7% | 1,723,382 | +0.1% | 0.02% | +25.0% |
| Q1 2019 | $150,611,000 | -9.3% | 1,721,667 | +3.8% | 0.01% | -20.0% |
| Q4 2018 | $165,989,000 | -21.5% | 1,659,058 | -10.1% | 0.02% | -6.2% |
| Q3 2018 | $211,405,000 | +30.0% | 1,845,061 | +1.7% | 0.02% | +14.3% |
| Q2 2018 | $162,634,000 | +58.4% | 1,813,427 | +29.2% | 0.01% | +55.6% |
| Q1 2018 | $102,674,000 | +26.5% | 1,403,388 | +0.4% | 0.01% | +28.6% |
| Q4 2017 | $81,165,000 | +35.6% | 1,397,511 | +4.8% | 0.01% | +40.0% |
| Q3 2017 | $59,854,000 | +13.9% | 1,333,858 | +0.2% | 0.01% | 0.0% |
| Q2 2017 | $52,562,000 | +2.2% | 1,330,994 | +5.0% | 0.01% | 0.0% |
| Q1 2017 | $51,449,000 | +9.3% | 1,268,107 | +8.3% | 0.01% | +25.0% |
| Q4 2016 | $47,057,000 | +19.9% | 1,170,641 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $39,258,000 | +32.9% | 1,084,089 | +6.4% | 0.00% | +33.3% |
| Q2 2016 | $29,544,000 | -18.0% | 1,019,216 | -1.1% | 0.00% | -25.0% |
| Q1 2016 | $36,042,000 | +9.7% | 1,030,394 | +1.1% | 0.00% | 0.0% |
| Q4 2015 | $32,853,000 | +2.0% | 1,019,023 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $32,196,000 | -28.4% | 996,164 | -8.4% | 0.00% | -20.0% |
| Q2 2015 | $44,956,000 | -11.9% | 1,087,035 | -4.3% | 0.01% | 0.0% |
| Q1 2015 | $51,033,000 | +19.9% | 1,136,038 | -0.2% | 0.01% | +25.0% |
| Q4 2014 | $42,574,000 | +6.5% | 1,137,763 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $39,982,000 | -3.2% | 1,144,861 | -2.2% | 0.00% | 0.0% |
| Q2 2014 | $41,285,000 | +7.4% | 1,170,248 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $38,428,000 | -60.1% | 1,179,082 | -49.2% | 0.00% | -33.3% |
| Q4 2013 | $96,242,000 | +105.2% | 2,319,867 | +97.3% | 0.01% | 0.0% |
| Q3 2013 | $46,903,000 | -3.4% | 1,176,064 | +0.1% | 0.01% | 0.0% |
| Q2 2013 | $48,565,000 | – | 1,174,458 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |